Emotional disorder adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From January 2004 to June 2026, FDA received 30,539 adverse event reports that record the MedDRA preferred term Emotional disorder. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 1,467 reports in the 12 months to June 2026 and 1,643 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 1 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 149 drug pages with 50 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Emotional disorder name as a suspect product, in order of name
Drug	Class	Reports with this term
Abilify	Atypical antipsychotic	304
Accutane	Retinoid	52
Actemra	Interleukin-6 receptor antagonist	105
Adderall	Central nervous system stimulant	102
Alprazolam	Benzodiazepine	51
Amitriptyline		117
Androgel		199
Aripiprazole	Atypical antipsychotic	99
Avandia		58
Avonex	Interferon beta	180
Bupropion hydrochloride	Aminoketone	116
Carbidopa levodopa	Aromatic amino acid	102
Celebrex	Nonsteroidal anti-inflammatory drug	67
Champix		72
Chantix	Partial cholinergic nicotinic agonist	700
Citalopram	Serotonin reuptake inhibitor	89
Clonazepam	Benzodiazepine	144
Codeine		53
Concerta	Central nervous system stimulant	104
Cosentyx	Interleukin-17A antagonist	102
Cymbalta	Serotonin and norepinephrine reuptake inhibitor	360
Depakote	Anti-epileptic agent	94
Desvenlafaxine succinate	Serotonin and norepinephrine reuptake inhibitor	149
Dexamethasone	Corticosteroid	70
Diazepam	Benzodiazepine	139
Digoxin	Cardiac glycoside	192
Dilaudid	Opioid agonist	96
Diovan	Angiotensin 2 receptor blocker	64
Domperidone		75
Duodopa		77
Dupixent	Interleukin-4 receptor alpha antagonist	276
Effexor	Serotonin and norepinephrine reuptake inhibitor	204
Eligard	Gonadotropin releasing hormone receptor agonist	81
Emflaza	Corticosteroid	51
Enbrel	Tumor necrosis factor blocker	342
Entresto	Angiotensin 2 receptor blocker	55
Escitalopram	Serotonin reuptake inhibitor	87
Fentanyl	Opioid agonist	54
Finasteride	5-alpha reductase inhibitor	74
Fluoxetine	Serotonin reuptake inhibitor	75
Forteo	Parathyroid hormone analog	82
Gabapentin	Anti-epileptic agent	123
Gilenya	Sphingosine 1-phosphate receptor modulator	154
Humira		591
Hydrocodone bitartrate and acetaminophen	Opioid agonist	88
Hydroxychloroquine	Antimalarial	73
Ibrance	Kinase inhibitor	201
Imbruvica	Kinase inhibitor	176
Incivek		50
Invega	Atypical antipsychotic	578
Invega Sustenna	Atypical antipsychotic	232
Jakafi	Janus kinase inhibitor	105
Keppra		115
Kesimpta	CD20-directed cytolytic antibody	64
Kisqali	Kinase inhibitor	69
Lamictal	Anti-epileptic agent	121
Lamotrigine	Anti-epileptic agent	102
Latuda	Atypical antipsychotic	97
Letrozole	Aromatase inhibitor	50
Levetiracetam		99
Lexapro	Serotonin reuptake inhibitor	82
Lorazepam	Benzodiazepine	136
Lupron Depot		122
Lyrica		405
Makena		62
Methotrexate	Folate analog metabolic inhibitor	176
Methylphenidate hydrochloride	Central nervous system stimulant	57
Metoclopramide	Dopamine-2 receptor antagonist	1,000
Metoclopramide hydrochloride	Dopamine-2 receptor antagonist	61
Mirena	Progestin	276
Mirtazapine		106
Montelukast	Leukotriene receptor antagonist	129
Morphine sulfate	Opioid agonist	95
Neurontin		88
Nexplanon	Progestin	136
Novothyrox		63
Nuplazid	Atypical antipsychotic	55
NuvaRing	Estrogen	160
Ocrevus	CD20-directed cytolytic antibody	54
Olanzapine	Atypical antipsychotic	70
Omeprazole	Proton pump inhibitor	129
Ondansetron	Serotonin-3 receptor antagonist	50
Orgovyx	Gonadotropin releasing hormone receptor antagonist	161
Otezla	Phosphodiesterase 4 inhibitor	101
Oxycodone	Opioid agonist	51
Oxycodone and acetaminophen	Opioid agonist	75
Oxycodone hydrochloride	Opioid agonist	177
OxyContin	Opioid agonist	230
ParaGard T 380A	Copper-containing intrauterine device	962
Paroxetine	Serotonin reuptake inhibitor	130
Paroxetine hydrochloride	Serotonin reuptake inhibitor	138
Paxil	Serotonin reuptake inhibitor	237
Pegasys	Interferon alpha	141
Plan B One-Step	Progestin	108
Prednisone	Corticosteroid	144
Premarin	Estrogen	113
Pristiq	Serotonin and norepinephrine reuptake inhibitor	117
Propecia	5-alpha reductase inhibitor	88
Prozac	Serotonin reuptake inhibitor	84
Quetiapine	Atypical antipsychotic	127
Quetiapine fumarate	Atypical antipsychotic	50
Rebif	Interferon beta	93
Reglan	Dopamine-2 receptor antagonist	90
Revlimid	Thalidomide analog	78
Ribavirin	Nucleoside analog antiviral	159
Risperdal	Atypical antipsychotic	5,494
Risperdal Consta		340
Risperdal M-Tab	Atypical antipsychotic	303
Risperidone	Atypical antipsychotic	2,833
Rituxan	CD20-directed cytolytic antibody	70
Rituximab	CD20-directed cytolytic antibody	74
Sandostatin LAR Depot		62
Seroquel	Atypical antipsychotic	311
Seroxat		73
Sertraline	Serotonin reuptake inhibitor	133
Singulair	Leukotriene receptor antagonist	211
Spravato		62
Strattera	Norepinephrine reuptake inhibitor	188
Suboxone	Opioid antagonist	59
Sulfasalazine	Aminosalicylate	75
Synthroid	l-Thyroxine	52
Tecfidera		137
Testim	Androgen	79
Topamax		122
Topiramate		54
Tramadol		163
Tramadol hydrochloride	Opioid agonist	51
Trasylol		56
Trikafta		68
Tysabri	Integrin receptor antagonist	402
Valproate sodium	Anti-epileptic agent	51
Venclexta	BCL-2 inhibitor	71
Venlafaxine	Serotonin and norepinephrine reuptake inhibitor	80
Venlafaxine hydrochloride	Serotonin and norepinephrine reuptake inhibitor	130
Viekira Pak		58
Vioxx		279
Vivitrol		74
Vyvanse	Central nervous system stimulant	163
Wellbutrin	Aminoketone	58
Xanax	Benzodiazepine	80
Xeljanz	Janus kinase inhibitor	131
Xolair	Anti-IgE	67
Xyrem	Central nervous system depressant	175
Yasmin		52
Yaz		77
Zantac		52
Zejula	Poly(ADP-Ribose) polymerase inhibitor	53
Zoloft	Serotonin reuptake inhibitor	225
Zyprexa	Atypical antipsychotic	132

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 45 pharmacologic classes with 100 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Emotional disorder name, in order of name
Class	Reports with this term
5-alpha reductase inhibitor	167
Aminoketone	284
Androgen	115
Angiotensin 2 receptor blocker	168
Anti-epileptic agent	610
Antimalarial	104
Aromatase inhibitor	117
Aromatic amino acid	116
Atypical antipsychotic	10,915
Benzodiazepine	740
Cardiac glycoside	192
CD20-directed cytolytic antibody	272
Central nervous system depressant	233
Central nervous system stimulant	677
Copper-containing intrauterine device	962
Corticosteroid	500
Dopamine-2 receptor antagonist	1,159
Estrogen	402
Folate analog metabolic inhibitor	219
Gonadotropin releasing hormone receptor antagonist	195
HMG-CoA reductase inhibitor	119
Integrin receptor antagonist	437
Interferon alpha	143
Interferon beta	295
Interleukin-17A antagonist	112
Interleukin-4 receptor alpha antagonist	284
Interleukin-6 receptor antagonist	105
Janus kinase inhibitor	277
Kinase inhibitor	792
Leukotriene receptor antagonist	382
Mood stabilizer	127
Nonsteroidal anti-inflammatory drug	194
Norepinephrine reuptake inhibitor	223
Nucleoside analog antiviral	159
Opioid agonist	1,158
Partial cholinergic nicotinic agonist	721
Phosphodiesterase 4 inhibitor	104
Progestin	604
Proton pump inhibitor	268
Retinoid	162
Serotonin and norepinephrine reuptake inhibitor	1,169
Serotonin reuptake inhibitor	1,456
Sphingosine 1-phosphate receptor modulator	163
Thalidomide analog	108
Tumor necrosis factor blocker	556

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Emotional disorder, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Emotional disorder
Age	Reports	Share
Under 2	66	0.2%
2 to 11	1,710	5.6%
12 to 17	1,086	3.6%
18 to 44	5,868	19.2%
45 to 64	5,084	16.6%
65 to 74	1,619	5.3%
75 and over	945	3.1%
Age not given	14,161	46.4%

Sex of the patient in the reports that record Emotional disorder
Sex	Reports	Share
Female	16,035	52.5%
Male	12,567	41.2%
Unknown or not given	1,937	6.3%

Age and sex are as the report gives them. 80.7% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Emotional disorder: adverse event reports that record this term. https://reportedreactions.com/reaction/emotional-disorder/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 1 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 1 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Oct 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Emotional disorder mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page